Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M335Revenue $M28.2Net Margin (%)-281.4Z-Score-3.9
Enterprise Value $M232EPS $-1.3Operating Margin %-275.2F-Score3
P/E(ttm))0Cash Flow Per Share $-1.8Pre-tax Margin (%)-281.4Higher ROA y-yN
Price/Book4.710-y EBITDA Growth Rate %0Quick Ratio5.5Cash flow > EarningsY
Price/Sales9.05-y EBITDA Growth Rate %-70.3Current Ratio5.9Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-58.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-114.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M70.5ROI % (ttm)-64.4Gross Margin Increase y-yY

Gurus Latest Trades with PACB

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PACBLee Ainslie 2013-09-30 Add0.17%$2.5 - $5.98
($3.45)
$ 5.559%Add 64.63%5,814,719
PACBJean-Marie Eveillard 2012-09-30 Sold Out -0.0013%$1.7 - $2.32
($1.97)
$ 5.5179%Sold Out0
PACBJohn Griffin 2012-06-30 Sold Out -0.05%$1.83 - $3.7
($2.48)
$ 5.5122%Sold Out0
PACBJean-Marie Eveillard 2012-03-31 Buy $2.94 - $5.04
($3.71)
$ 5.548%New holding, 150000 sh.150,000
PACBGeorge Soros 2011-09-30 Sold Out -0.0018%$3.55 - $12.24
($7.91)
$ 5.5-30%Sold Out0
PACBGeorge Soros 2011-06-30 Buy $10.44 - $13.53
($11.8)
$ 5.5-53%New holding, 10700 sh.10,700
PACBJohn Griffin 2011-03-31 Buy 0.21%$12.94 - $16.3
($15)
$ 5.5-63%New holding, 870000 sh.870,000
PACBLee Ainslie 2010-12-31 Buy 0.54%$11.53 - $16.97
($13.88)
$ 5.5-60%New holding, 3543333 sh.3,543,333
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PACB is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PACB Lee Ainslie 2014-03-316,459,7849.160.48
Premium Most recent portfolio changes are included for Premium Members only!


PACB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hunkapiller MichaelChairman, CEO & President 2013-12-12Buy100,000$4.1333.41view
Hunkapiller MichaelChairman, CEO & President 2013-11-21Buy200,000$3.6152.63view
Hunkapiller MichaelChairman, CEO & President 2012-12-03Buy154,100$1.75214.86view
Hunkapiller MichaelChairman, CEO & President 2012-11-29Buy242,200$1.68227.98view
Hunkapiller MichaelChairman, CEO & President 2012-11-26Buy186,400$1.44282.64view
Hunkapiller MichaelChairman, CEO & President 2012-11-20Buy155,000$1.27333.86view
Hunkapiller MichaelChairman, CEO & President 2012-11-16Buy262,300$1.16375view
Hunkapiller MichaelChairman, CEO & President 2012-08-07Buy400,000$1.75214.86view
Hunkapiller MichaelDirector 2011-08-10Buy100,000$5.77-4.51view
Turner Stephen WVP & Chief Technology Officer 2011-07-06Sell67,900$12.05-54.27view

Press Releases about PACB :

    Quarterly/Annual Reports about PACB:

    News about PACB:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: CLR, CLMS, OPK, PACB, GAIN Dec 16 2013 
    Weekly CEO Buys Highlight: OPK, PACB, CUBI, ARCP, RLYP Nov 25 2013 
    Weekly CEO Buys Highlight: PHII, TUES, PACB, IPHI, WMC Dec 09 2012 
    Weekly CEO Buys Highlight: PACB, AKS, EPIQ, GGS, TPGI Dec 02 2012 
    Weekly CEO Buys Highlight: FFIN, STEC, MPO, PACB, TPGI Nov 25 2012 
    Weekly CEO Buys Highlight: SUNS, PACB, GM, NPO, DGX Aug 11 2012 

    More From Other Websites
    Pacific Biosciences of California, Inc. Second Quarter 2014 Financial Results Call Jul 02 2014
    Pacific Biosciences of California, Inc. Second Quarter 2014 Financial Results Call Jul 02 2014
    Pacific Biosciences, GenDx initiate co-marketing activities for full-length HLA Jun 19 2014
    Pacific Biosciences and GenDx Initiate Co-Marketing Activities for Full-Length HLA Gene Sequencing... Jun 19 2014
    PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 8-K, Submission of Matters to a Vote of... May 23 2014
    Nasdaq stocks posting largest percentage increases May 20 2014
    American Society for Microbiology to hold a meeting May 19 2014
    PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Financials May 16 2014
    Single Molecule, Real-Time (SMRT) DNA Sequencing Technology From Pacific Biosciences to be Featured... May 14 2014
    Anthony Nolan Revolutionizes HLA Typing With Breakthrough DNA Sequencing Technology From Pacific... May 13 2014
    Pacific Biosciences Of California: An Underrated DNA Sequencer Gaining Traction May 13 2014
    PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 10-Q, Quarterly Report May 08 2014
    Why Pacific Biosciences of California (PACB) Stock Is Surging Today May 01 2014
    Pacific Biosciences upgraded to Neutral from Underweight at JPMorgan May 01 2014
    Pacific Biosciences of California Management Discusses Q1 2014 Results - Earnings Call Transcript Apr 30 2014
    PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 8-K, Results of Operations and Financial... Apr 30 2014
    Pacific Biosciences of California, Inc. Announces First Quarter 2014 Financial Results Apr 30 2014
    Q1 2014 Pacific Biosciences Of California Inc Earnings Release - After Market Close Apr 30 2014
    HistoGenetics Selects PacBio(R) DNA Sequencing Platform to Enhance Human Leukocyte Antigen (HLA)... Apr 29 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide